Acorah Software Products - Accounts Production 15.0.600 true true false 3 February 2023 28 February 2024 28 February 2024 SC757605 Dr Colin Smith Dr Tammaryn Claire Lashley Dr Daniel Gerhardus du Plessis iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure SC757605 2023-02-02 SC757605 2024-02-28 SC757605 2023-02-03 2024-02-28 SC757605 frs-core:ShareCapital 2024-02-28 SC757605 frs-bus:PrivateLimitedCompanyLtd 2023-02-03 2024-02-28 SC757605 frs-bus:AbridgedAccounts 2023-02-03 2024-02-28 SC757605 frs-bus:SmallEntities 2023-02-03 2024-02-28 SC757605 frs-bus:EntityHasNeverTraded 2023-02-03 2024-02-28 SC757605 frs-bus:AuditExempt-NoAccountantsReport 2023-02-03 2024-02-28 SC757605 frs-bus:SmallCompaniesRegimeForAccounts 2023-02-03 2024-02-28 SC757605 frs-bus:Director1 2023-02-03 2024-02-28 SC757605 frs-bus:Director2 2023-02-03 2024-02-28 SC757605 frs-bus:Director3 2023-02-03 2024-02-28 SC757605 frs-countries:Scotland 2023-02-03 2024-02-28
Registered number: SC757605
Neuropathology 2027 Limited
Unaudited ABRIDGED Dormant Financial Statements
For the Period 3 February 2023 to 28 February 2024
Ballantyne & Co
Chartered Accountants & Registered Auditors
60 St. Enoch Square
Glasgow
G1 4AG
Contents
Page
Abridged Balance Sheet 1
Notes to the Abridged Financial Statements 2
Page 1
Abridged Balance Sheet
Registered number: SC757605
28 February 2024
Notes £ £
CURRENT ASSETS
Cash at bank and in hand 1
1
NET CURRENT ASSETS (LIABILITIES) 1
TOTAL ASSETS LESS CURRENT LIABILITIES 1
NET ASSETS 1
CAPITAL AND RESERVES
Called up share capital 4 1
SHAREHOLDERS' FUNDS 1
For the period ending 28 February 2024 the company was entitled to exemption from audit under section 480 of the Companies Act 2006 relating to dormant companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime.
The company has taken advantage of section 444(1) of the Companies Act 2006 and opted not to deliver to the registrar a copy of the company's Profit and Loss Account.
All of the company's members have consented to the preparation of an Abridged Balance Sheet for the year end 28 February 2024 in accordance with section 444(2A) of the Companies Act 2006.
On behalf of the board
Dr Colin Smith
Director
15 October 2024
The notes on page 2 form part of these financial statements.
Page 1
Page 2
Notes to the Abridged Financial Statements
1. General Information
Neuropathology 2027 Limited is a private company, limited by shares, incorporated in Scotland, registered number SC757605 . The registered office is 60 St. Enoch Square, Glasgow, G1 4AG.
2. Accounting Policies
2.1. Basis of Preparation of Financial Statements
The financial statements have been prepared under the historical cost convention and in accordance with Financial Reporting Standard 102 section 1A Small Entities "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006.
3. Average Number of Employees
Average number of employees, including directors, during the period was:
-
4. Share Capital
28 February 2024
£
Allotted, Called up and fully paid 1
Page 2